Marco Quarta

Marco Quarta

Company: Rubedo Life Sciences

Job title: Co-Founder & Chief Executive Officer

Seminars:

Roundtable Discussion: An Evaluation of the Rise of Senolytics & the Future of Targeting Senolytic Cells 3:00 pm

Join your session leaders in this roundtable as they spark conversation on: The sudden rise in targeting senescent cells Novel clinical and preclinical trials that are progressing in the senescent space Discussing whether research should be focus solely on cellular senescence or take a cocktail approach alongside other hallmarks of agingRead more

day: Day One

Computational Discovery of Cellular Senescence in Age-Related Diseases to Develop Selective Senolytics 2:30 pm

Discussing the definition of senescent cells as heterogeneous cell populations and considering that not all senescent cells are pathological cells Assessing bioinformatic strategies that enable the discovery of senescent cell types to target in specific age-related diseases Examining the development of selective novel classes of senolytics for effective pharmacological strategies to treat age-related diseasesRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.